Dental management of patients receiving oral bisphosphonate therapy

Bisphosphonate-Induced Exposed Bone (Osteonecrosis/Osteopetrosis) of the Jaws: Risk Factors, Recognition, Prevention, and Treatment

Robert E. Marx, Yoh Sawatari, Michel Fortin et al. · Journal of Oral and Maxillofacial Surgery · 2005 · 1.6K citations

Medicine, Oral Pathology, Oral Surgery +12

Severely Suppressed Bone Turnover: A Potential Complication of Alendronate Therapy

Clarita V. Odvina, Joseph E. Zerwekh, D. Sudhaker Rao et al. · The Journal of Clinical Endocrinology & Metabolism · 2005 · 1.4K citations · Full text

Medicine, Orthopaedic Surgery, Orthopedic Surgery +13

Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure.

Masahiko Sato, W A Grasser, Naoto Endo et al. · Journal of Clinical Investigation · 1991 · 1K citations · Full text

Medicine, Endocrinology, Bone Augmentation +14

Suppressed Bone Turnover by Bisphosphonates Increases Microdamage Accumulation and Reduces Some Biomechanical Properties in Dog Rib

Tasuku Mashiba, Tôru Hirano, Charles H. Turner et al. · Journal of Bone and Mineral Research · 2000 · 696 citations · Full text

Medicine, Orthopedic Surgery, Bone Augmentation +16

Bisphosphonates inhibit angiogenesis in vitro and testosterone-stimulated vascular regrowth in the ventral prostate in castrated rats.

Pierrick G.J. Fournier, Stéphanie Filleur, Julien Guglielmi et al. · PubMed · 2002 · 571 citations

Medicine, Endocrinology, Pharmacology +15